Perbandingan Kadar Serum Il-2 Pada Gastritis H.Pylori Dengan Gastritis Non H.Pylori
DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007 ;13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005; 36:228-33.
3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of
Clinical Investigation. 2007; 17:60-9.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol. 2005; 36(1):261-6.
5. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect.
2001; 126:37-42.
6. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
7. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in
patients with Helicobacter pylori infection. Tokai J Exp Clin Med. 2005;
30(2):83-8.
8. Salama NR, Hartung ML, Müller Anne. Life in the human stomach:
persistence strategies of the bacterial pathogen Helicobacter pylori. Nature
Reveiws Microbiol. 2013;11:385-99
9. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
67
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular SignalRegulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
10. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143.
11. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha)
prevents HCl/ethanol induced gastric injury in Sprague Dawley rats.
Molecular Medicine Reports. 2013; 7:1613-6
12. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul: 2012: hlm
1-80.
13. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512.
14. Nafiah, Pengaruh Lama Fermentasi Terhadap Jumlah Koloni Bakteri Asam
Laktat Dalam Soyghurt Dan Efektifitas Pada Penyembuhan Gastritis
Lambung Mencit (Mus musculus L) Yang Diinduksi Dengan Aspirin.
[Diunduh
19
Maret
2015].
Tersedia
dari:
http://repository.usu.ac.id/handle/123456789/38265.
15. Adibi
P.
Gastritis.
[Diunduh
9
Maret
2015].
Tersedia
dari:
http://med.mui.ac.ir
16. Szoke D. Genetic factors related to the histological and macroscopic lesions
of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 761.
17. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373–
84.
18. Wehbi M. Acute gastritis. Medscape. 2014
19. Loyd RA, McClellan DA. Update on the evaluation and management of
functional dyspepsia. Am Fam Physician. 2011;83(5):547-52.
20. Meyer F, Wilson KT, James SP. Modulation of Innate Cytokine Response by
Products of Helicobacter pylori. Infection and Immunity. Nov 2000;6265-72
68
21. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
22. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
23. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of
prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56(Suppl 3):33-55.
24. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, et al. Incidence of
gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled
results from three 12-week trials in Chinese patients with osteoarthritis or
rheumatoid arthritis. Int J Rheum Dis. 2010: 13(2): 151–7.
25. Blaser MJ. Who are we? Indigenous microbes and the ecology of human
disease. EMBO Reports. 2006;7(10): 956–60
26. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected
gastric epithelial cells reveals a cell-type specific response to Helicobacter
pylori infection. Gastroenterology. 2004;127:1446–62.
27. Suerbaum S, Michetti P. Helicobacter Pylori Infection. N Engl J Med. 2002:
347(15):1175-86.
28. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling
the
Intricacies
of
Helicobacter
pylori-induced
Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad.
In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers;
2013. Chapter 7.
29. Ricci V, Giannouli, Romano M, Zarrilli R. Helicobacter pylori gammaglutamyl transpeptidase and its pathogenic role. World J of Gastroenterol.
2014; 20(3) : 630-8.
30. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis
and Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill. 2009; hlm.175-83.
31. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N,
Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal Anti-
69
Inflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol.
2013; 14(2):87-92.
32. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
33. Naito Y, Yoshikawa T. Molecular and cellular mechanism involved in
Helicobacter pylori induced inflammation and oxidative stress. Free Rad Biol
and Med. 2002;33:323-6.
34. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract
against NSAID induced gastric ulcer: role of proinflammatory cytokines and
oxidative damage. Chem Biol Interact. 2006;161:262–70.
35. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz
D, et al. Activation of genes for superoxide dismutase, interleukin-1beta,
tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during
healing
of
ischemia-reperfusion-induced
gastric
injury.
Scand
J
Gastroenterol. 2000;35(5):452-63.
36. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
37. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50.
38. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105.
39. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
40. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling
blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA
binding. J Biol Chem. 1999;274:31868-74.
70
41. Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori
stimulation of interleukin-8 production in a gastric epithelial cell line (MKN
28): roles of mitogen-activated protein kinase and interleukin-1beta. Biochem
Pharmacol. 2001;61:1595-604.
42. Zakaria Z, Devaney RJ, Atherthon JC, Robinson K. Effects of interleukin-10
on the gastric epithelial cell response to Helicobacter pylori. In 8th
International Workshop on Pathogenesis and Host Response in Helicobacter
Infections, 5th July, Helsingor, Denmark; 2008.hlm. HP-76.
43. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development
and control of inflammatory disease. Immun Reviews. 2008; 226:19-28
44. Sander GB, Mazzoleni LE, Francesconi CFM, Wortmann AC, Ott EA, Theil
A, et al. Development and Validation of a Cross-Cultural Questionnaire to
Evaluate Nonulcer Dyspepsia: The Porto Alegre Dyspeptic Symptoms
Questionnaire
(PADYQ).
Digestive
Diseases
and
Sciences.
2004:49(11/12):1822-9
45. Chen H, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter
pylori
Infection
Decreases
Gastritis. Gastroenterology
with
Older
Research
Age
in
and
Atrophic
Practice.
2013:Aug;21(2013)http://dx.doi.org/10.1155/2013/494783
46. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positivity in the Australian adult
community. J Gastroenterology Hepatology.2011 ;Aug;26(8):1283-9
47. Betty. Infeksi Helicobacter pylori pada lesi gastritis yang didiagnosa dengan
Pewarnaan Histokimia Giemsa dan Imunohistokimia Helicobacter pylori di
Laboratorium Patologi Anatomi Fakultas Kedokteran USU Medan. 2012.
http://repository.usu.ac.id/handle/123456789/34694
48. Parameswaran I, Hubungan peningkatan kadar leukosit dan neutropil dengan
infeksi
H.pylori
di
RSU
Permata
Bunda
Medan.2014.
http://repository.usu.ac.id/handle/123456789/41610.
49. Zho Y, et al. Risk factors and prevalence of H.Pylori infection in persistent
high incidence area of gastric carcinoma in Yangzhong city.2014.
http://dx.doi.org/10.1155/2014/481365
71
50. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik
factors.Jurnal canadian of gastroenterologi. 2007:21(8):501-506
51. Abidiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, et
al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks.
Nagoya J Med Sci, 2010;72:167-72
52. Fan XG, Yakoob J, Fan Xj, Keeling PWN. A change of IL-2 and IL-4
production in patients with Helicobacter pylori infection. Mediators of
Inflammation, 1995;4:289-92
53. Rudnicka W, Jarosinka A, Bak-Romaniszyn L, Moran A, Planeta-Malecka I,
Wadstrom T, et al. Helicobacter pylori lipopolysaccharide in the IL-2 milieu
activates lymphocytes from dyspeptic children. FEMS Immun and Med
Microbiol, 2003;36:141-5
54. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al.
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a
T helper cell 1 phenotype. Gastroenterol, 1998;114(3):482-92.
55. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
56. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate
with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia.
Trop Gastroenterol 2001;22:194-6.
72
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007 ;13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005; 36:228-33.
3. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of
Clinical Investigation. 2007; 17:60-9.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and
molecular diagnosis of Helicobacter pylori in benign lesions and gastric
adenocarcinoma. Braz J Microbiol. 2005; 36(1):261-6.
5. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect.
2001; 126:37-42.
6. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
7. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al.
Relationship between gastric mucosal IL-8 levels and histological gastritis in
patients with Helicobacter pylori infection. Tokai J Exp Clin Med. 2005;
30(2):83-8.
8. Salama NR, Hartung ML, Müller Anne. Life in the human stomach:
persistence strategies of the bacterial pathogen Helicobacter pylori. Nature
Reveiws Microbiol. 2013;11:385-99
9. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H,
Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a
Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis
Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and
Helicobacter Pylori Bacterial Components in Human Monocytic Cells via
67
Inhibition of Activation of Nuclear Factor-kappaB and Extracellular SignalRegulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
10. Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of
Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the
proton pump inhibitor pantoprazole against indomethacin-induced gastric
damage in rats. BMC Gastroenterology. 2012;12:143.
11. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha)
prevents HCl/ethanol induced gastric injury in Sprague Dawley rats.
Molecular Medicine Reports. 2013; 7:1613-6
12. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul: 2012: hlm
1-80.
13. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512.
14. Nafiah, Pengaruh Lama Fermentasi Terhadap Jumlah Koloni Bakteri Asam
Laktat Dalam Soyghurt Dan Efektifitas Pada Penyembuhan Gastritis
Lambung Mencit (Mus musculus L) Yang Diinduksi Dengan Aspirin.
[Diunduh
19
Maret
2015].
Tersedia
dari:
http://repository.usu.ac.id/handle/123456789/38265.
15. Adibi
P.
Gastritis.
[Diunduh
9
Maret
2015].
Tersedia
dari:
http://med.mui.ac.ir
16. Szoke D. Genetic factors related to the histological and macroscopic lesions
of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 761.
17. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373–
84.
18. Wehbi M. Acute gastritis. Medscape. 2014
19. Loyd RA, McClellan DA. Update on the evaluation and management of
functional dyspepsia. Am Fam Physician. 2011;83(5):547-52.
20. Meyer F, Wilson KT, James SP. Modulation of Innate Cytokine Response by
Products of Helicobacter pylori. Infection and Immunity. Nov 2000;6265-72
68
21. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
22. Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on
healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
23. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of
prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56(Suppl 3):33-55.
24. Cheung R, Cheng TT, Dong Y, Lin HY, Lai K, Lau CS, et al. Incidence of
gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled
results from three 12-week trials in Chinese patients with osteoarthritis or
rheumatoid arthritis. Int J Rheum Dis. 2010: 13(2): 151–7.
25. Blaser MJ. Who are we? Indigenous microbes and the ecology of human
disease. EMBO Reports. 2006;7(10): 956–60
26. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected
gastric epithelial cells reveals a cell-type specific response to Helicobacter
pylori infection. Gastroenterology. 2004;127:1446–62.
27. Suerbaum S, Michetti P. Helicobacter Pylori Infection. N Engl J Med. 2002:
347(15):1175-86.
28. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling
the
Intricacies
of
Helicobacter
pylori-induced
Gastric
Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad.
In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers;
2013. Chapter 7.
29. Ricci V, Giannouli, Romano M, Zarrilli R. Helicobacter pylori gammaglutamyl transpeptidase and its pathogenic role. World J of Gastroenterol.
2014; 20(3) : 630-8.
30. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis
and Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill. 2009; hlm.175-83.
31. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N,
Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal Anti-
69
Inflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol.
2013; 14(2):87-92.
32. Eamlamnam K, Patumraj S, Visedopas N, et al. Effects of Aloe vera and
sucralfate on gastric microcirculatory changes, cytokine levels and gastric
ulcer healing in rats. World J Gastroenterol. 2006;12:2034-9.
33. Naito Y, Yoshikawa T. Molecular and cellular mechanism involved in
Helicobacter pylori induced inflammation and oxidative stress. Free Rad Biol
and Med. 2002;33:323-6.
34. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract
against NSAID induced gastric ulcer: role of proinflammatory cytokines and
oxidative damage. Chem Biol Interact. 2006;161:262–70.
35. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz
D, et al. Activation of genes for superoxide dismutase, interleukin-1beta,
tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during
healing
of
ischemia-reperfusion-induced
gastric
injury.
Scand
J
Gastroenterol. 2000;35(5):452-63.
36. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90.
37. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50.
38. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H.
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology. 2002;123(1):92-105.
39. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al.
Gastric mucosal cytokine responses in Helicobacter pylori-infected patients
with gastritis and peptic ulcers. Association with inflammatory parameters
and bacteria load. FEMS Immunology and Medical Microbiology.
2003;36:175-80.
40. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS. Interleukin-10 signaling
blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA
binding. J Biol Chem. 1999;274:31868-74.
70
41. Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori
stimulation of interleukin-8 production in a gastric epithelial cell line (MKN
28): roles of mitogen-activated protein kinase and interleukin-1beta. Biochem
Pharmacol. 2001;61:1595-604.
42. Zakaria Z, Devaney RJ, Atherthon JC, Robinson K. Effects of interleukin-10
on the gastric epithelial cell response to Helicobacter pylori. In 8th
International Workshop on Pathogenesis and Host Response in Helicobacter
Infections, 5th July, Helsingor, Denmark; 2008.hlm. HP-76.
43. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development
and control of inflammatory disease. Immun Reviews. 2008; 226:19-28
44. Sander GB, Mazzoleni LE, Francesconi CFM, Wortmann AC, Ott EA, Theil
A, et al. Development and Validation of a Cross-Cultural Questionnaire to
Evaluate Nonulcer Dyspepsia: The Porto Alegre Dyspeptic Symptoms
Questionnaire
(PADYQ).
Digestive
Diseases
and
Sciences.
2004:49(11/12):1822-9
45. Chen H, Ying L, Kong M, Zhang Y, Li Y. The Prevalence of Helicobacter
pylori
Infection
Decreases
Gastritis. Gastroenterology
with
Older
Research
Age
in
and
Atrophic
Practice.
2013:Aug;21(2013)http://dx.doi.org/10.1155/2013/494783
46. Pandeya N, Whiteman DC, Australian Cancer Study. Prevalence and
determinants of Helicobacter pylori sero-positivity in the Australian adult
community. J Gastroenterology Hepatology.2011 ;Aug;26(8):1283-9
47. Betty. Infeksi Helicobacter pylori pada lesi gastritis yang didiagnosa dengan
Pewarnaan Histokimia Giemsa dan Imunohistokimia Helicobacter pylori di
Laboratorium Patologi Anatomi Fakultas Kedokteran USU Medan. 2012.
http://repository.usu.ac.id/handle/123456789/34694
48. Parameswaran I, Hubungan peningkatan kadar leukosit dan neutropil dengan
infeksi
H.pylori
di
RSU
Permata
Bunda
Medan.2014.
http://repository.usu.ac.id/handle/123456789/41610.
49. Zho Y, et al. Risk factors and prevalence of H.Pylori infection in persistent
high incidence area of gastric carcinoma in Yangzhong city.2014.
http://dx.doi.org/10.1155/2014/481365
71
50. Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik
factors.Jurnal canadian of gastroenterologi. 2007:21(8):501-506
51. Abidiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, et
al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks.
Nagoya J Med Sci, 2010;72:167-72
52. Fan XG, Yakoob J, Fan Xj, Keeling PWN. A change of IL-2 and IL-4
production in patients with Helicobacter pylori infection. Mediators of
Inflammation, 1995;4:289-92
53. Rudnicka W, Jarosinka A, Bak-Romaniszyn L, Moran A, Planeta-Malecka I,
Wadstrom T, et al. Helicobacter pylori lipopolysaccharide in the IL-2 milieu
activates lymphocytes from dyspeptic children. FEMS Immun and Med
Microbiol, 2003;36:141-5
54. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al.
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a
T helper cell 1 phenotype. Gastroenterol, 1998;114(3):482-92.
55. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;46-v26
56. Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate
with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia.
Trop Gastroenterol 2001;22:194-6.
72